Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive ImpairmentLi Su, Lawrence Hayes, Soteris Soteriades, et al.
Breast Cancer Research and Treatment|September 6, 2019
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie databaseE Kaczmarek, C Saint-Martin, J-Y Pierga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2020
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆F Montemurro, S Delaloge, C H Barrios, et al.
Gynecologic Oncology|October 18, 2011
Withdrawal from familial ovarian cancer screening for surgery: findings from a psychological evaluation study (PsyFOCS)Kate J Lifford, Lindsay Fraser, Adam N Rosenthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2015
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancerJ O'Shaughnessy, M Campone, E Brain, et al.
NPJ Precision Oncology|May 2, 2025
Kinome profiling reveals pathogenic variant specific protein signalling networks in MEN2 children with Medullary Thyroid CancerB Rix, R Chauhan, Z Masoumi, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 27, 2022
Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud studyMbasan Jallow, Georgia Black, Sandra van Os, et al.
British Journal of Cancer|January 14, 2012
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2E Brain, N Isambert, F Dalenc, et al.
British Journal of Cancer|October 20, 2011
High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancerE Brain, C Levy, D Serin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2013
Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trialC Falandry, E Brain, M Bonnefoy, et al.
Pageof 11